Search results for: 'test research'

14 Mar 2022  |  North America  |  Market Outlook

Next-generation Diagnostics Outlook, 2022

Recovery in Routine Testing and Focus on Personalized Diagnostics to Propel Growth

Infographics

×

In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...

The impact of the convergence of Information Technology (IT) and Operational Technology (OT) has been tremendous in recent times. Benefits of this convergence can be seen even in traditional markets (e.g., mechanical testing). The world is staring at an economic mess propelled by the catastrophic outbreak of COVID-19. In 2020, the demand for digita...

The medical imaging and informatics industry is evolving, with vendors launching new products and solutions every other day. As the reimbursement environment transitions from fee-for-service to value-based payment, vendors business models and value propositions are changing. New evidence on the use of specific imaging techniques is influencing chan...

The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...

A mobility living lab is a test bed and key tool for open innovation in the connected, automated, shared, and electric (CASE) mobility domain. Living labs enable collaboration between regional governmental authorities, research institutions, and OEMs to develop technologies in a real-life environment best suited for specific local mobility landscap...

Clinical genomics regained significance during the pandemic with the development of the mRNA COVID-19 vaccine, and several non-invasive at-home test kits; an unprecedented feat in recent times. Genomics will take center stage, as large genome sequencing and research will continuously create data for new therapeutics. Artificial Intelligence (AI) an...

The change in reimbursement for diagnostic testing, pressure from PAMA, regulatory trends in Europe, demand for large-scale testing, shift to precision diagnostics, emerging companies, and evolving business models demand assessing portfolio, evaluating competitor strategies, and exploring opportunities for business growth. The competitive nature of...

This Frost & Sullivan research service focuses on US Department of Defense (DoD) artificial intelligence (AI) budget spending and contracts. Artificial intelligence tools are used across an array of DoD applications to enhance mission accomplishment and safety, including logistics, maintenance, healthcare, administration, networks, intelligence ana...

This research service focuses on the United States (US) Department of Defense (DoD) artificial intelligence (AI) contracting information for research, development, test, and evaluation (RDT&E); procurement; and services. The analyst has segmented contracting data by military department and overall leading firms. The data and insight provided are ca...